LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)

• Status: Completed
• Trial end date: 2009-09-01

Summary

The primary objective of this study is to evaluate efficacy, arterial stiffness measured by Pulse Wave Velocity (PWV) of Losartan potassium group compared to Carvedilol group after 24 weeks of treatment in patients with the essential hypertension.

• Phase: Phase 4

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Carvedilol; Hydrochlorothiazide; Losartan